Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TPE/4119 stock hub

TPE/4119 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPE/4119is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

5.6B

Taiwan Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPE/4119

In the news

Latest news · TPE/4119

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12P50 15.5P75 22.5

Trailing P/E58.2

P25 14.4P50 18P75 31.9

ROE1.7

P25 -16.2P50 0.3P75 9.8

ROIC2.5

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPE/4119 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

233

Groups with data

Currency

TWD

Showing 233 of 233 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Employees	245
Employees Change	19%
Employees Change Percent	8.41
Enterprise value	TWD 6.3B
Exchange	Taiwan Stock Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	TW0004119003
Last refreshed	2026-05-10
Market cap	TWD 5.6B
Price	TWD 46.65
Price currency	TWD
Rev Per Employee	5,687,138.08x
Sector	Healthcare
Sic	2834
Symbol	tpe/4119
Website	https://www.sci-pharmtech.com.tw

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.72%
EV Earnings	65.39x
EV/EBIT	60.7x
EV/EBITDA	17.53x
EV/FCF	-20.1x
EV/Sales	4.61x
FCF yield	-5.59%
P/B ratio	1.03x
P/E ratio	58.23x
P/S ratio	4.1x
PE Ratio10 Y	33.59x
PE Ratio3 Y	39x
PE Ratio5 Y	49.99x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	11.33%
EBITDA Margin	29.65%
Gross margin	26.06%
Gross Profit	TWD 354.2M
Gross Profit Growth	-11%
Gross Profit Growth Q	4%
Gross Profit Growth3 Y	-0.45%
Gross Profit Growth5 Y	-18.94%
Net Income	TWD 95.7M
Net Income Growth	-81.65%
Net Income Growth Q	-36.63%
Net Income Growth Years	0%
Net Income Growth3 Y	-33.87%
Net Income Growth5 Y	-13.12%
Pretax Margin	6.72%
Profit Margin	7.04%
Profit Per Employee	TWD 400,619
Profitable Years	17
ROA	1.37
Roa5y	1.51
ROCE	2.61
ROE	1.75
Roe5y	5.88
ROIC	2.48
Roic5y	2.74

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	0.17%
Cagr15y	4.1%
Cagr1y	-32.08%
Cagr20y	12.9%
Cagr3y	-24.42%
Cagr5y	-5.63%
Div CAGR10	-6.2%
Div CAGR3	81.71%
Div CAGR5	27.54%
EPS Growth	-81.58
EPS Growth Q	-35.28
EPS Growth Years	0
EPS Growth3 Y	-36.15
EPS Growth5 Y	-14.82
OCF Growth	-82.18%
OCF Growth Q	-65.06%
OCF Growth10 Y	-11.99%
OCF Growth3 Y	-27.31%
OCF Growth5 Y	-30.57%
Revenue Growth	-13.65x
Revenue Growth Q	4.3x
Revenue Growth Years	0x
Revenue Growth3 Y	8.86x
Revenue Growth5 Y	-9.42x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.19
Assets	TWD 7B
Cash	TWD 53M
Current Assets	TWD 1.1B
Current Liabilities	TWD 1.1B
Debt	TWD 739.1M
Debt EBITDA	TWD 1.81
Debt Equity	TWD 0.14
Debt FCF	TWD -2.37
Equity	TWD 5.4B
Interest Coverage	24.99
Liabilities	TWD 1.5B
Long Term Assets	TWD 5.9B
Long Term Liabilities	TWD 490.9M
Net Cash	TWD -686.1M
Net Cash By Market Cap	TWD -12.31
Net Debt EBITDA	TWD 1.7
Net Debt Equity	TWD 0.13
Tangible Book Value	TWD 5.4B
Tangible Book Value Per Share	TWD 45.04
WACC	4.3

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.05
Inventory Turnover	1.57
Net Working Capital	TWD 394M
Quick ratio	0.37
Working Capital	TWD 51.3M
Working Capital Turnover	TWD 5

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.39%
Dividend Growth	20%
Dividend Growth Years	2%
Dividend per share	TWD 0.75
Dividend Years	3
Dividend Yield	1.61%
Ex Div Date	2025-07-01
Last Dividend	TWD 1.5
Payout Frequency	Annual
Payout Ratio	187.22%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	1.75%
1Y total return	-32.07%
200-day SMA	54.19
3Y total return	-56.84%
50-day SMA	50.88
50-day SMA vs 200-day SMA	50under200
5Y total return	-25.15%
All Time High	119.6
All Time High Change	-60.98%
All Time High Date	2023-04-19
All Time Low	6.85
All Time Low Change	581.22%
All Time Low Date	2005-09-22
ATR	0.97
Beta	0.1
Beta1y	0.2
Beta2y	0.26
Ch YTD	-4.21
High	47.7
High52	72.4
High52 Date	2025-05-09
High52ch	-35.57%
Low	46.55
Low52	46.55
Low52 Date	2026-05-08
Low52ch	0.21%
Ma50ch	-8.32%
Price vs 200-day SMA	-13.92%
RSI	32.45
RSI Monthly	26.55
RSI Weekly	31.42
Sharpe ratio	-1.69x
Sortino ratio	-2.01
Total Return	2%
Tr YTD	-4.21
Tr15y	82.81%
Tr1m	-10.46%
Tr1w	-1.06%
Tr3m	-10.12%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD 154.1M
Operating Income Growth	-17.87
Operating Income Growth Q	-3.43
Operating Income Growth3 Y	-4.97
Operating Income Growth5 Y	-28.57
Operating margin	11.33

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	72,115,920%
Net Borrowing	84,360,000
Shares Insiders	5.4%
Shares Institutions	0.64%
Shares Out	119,508,634
Shares Qo Q	-0.43%
Shares Yo Y	-0.39%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD -311.4M
Average Volume	225,026.6x
Bv Per Share	45.27
CAPEX	TWD -463.1M
Ch10y	-23.29
Ch15y	12.66
Ch1m	-10.46
Ch1w	-1.06
Ch1y	-33.64
Ch20y	474
Ch3m	-10.12
Ch3y	-59.16
Ch5y	-29.56
Ch6m	-16.99
Change	-1.37%
Change From Open	-1.79
Close	47.3
Days Gap	0.42
Depreciation Amortization	248,917,000
Dollar Volume	8,552,437.8
Earnings Date	2026-05-15
EBIT	TWD 154.1M
EBITDA	TWD 403M
EPS	TWD 0.8
F Score	6
FCF	TWD -311.4M
FCF EV Yield	-4.97x
FCF Per Share	TWD -2.61
Financing CF	-94,985,000
Fiscal Year End	December
Founded	1,987
Graham Number	28.56795
Graham Upside	-38.76
Income Tax	TWD -4.4M
Investing CF	-391,619,000
Is Primary Listing	1
Last Earnings Date	2025-11-10
Last Report Date	2026-03-31
Last Split Date	2023-07-27
Last Split Type	Forward
Lynch Fair Value	TWD 4.01
Lynch Upside	-91.41
Ma150	52.28
Ma150ch	-10.77%
Ma20	48.33
Ma20ch	-3.48%
Net CF	-334,976,000
Next Earnings Date	2026-05-15
Open	47.5
P OCF Ratio	36.77
Payment Date	2025-08-05
Position In Range	8.7
Ppne	5,154,923,000
Price Date	2026-05-08
Price EBITDA	TWD 13.83
Ptbv Ratio	1.04
Relative Volume	0.81x
Revenue	1,359,226,000x
Tax By Revenue	-0.32x
Tr20y	1,032.68%
Tr6m	-16.99%
Volume	183,332

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TPE/4119 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.6%

$0.75 annual per share

Payout ratio

+187.2%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+27.5%

2 consecutive years of growth

Total shareholder yield

+2.0%

Next ex-dividend date: 2025-07-01

Performance

TPE/4119 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPE/4119?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.6%

Share of float held by funds and institutions

Insider ownership

+5.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.4%

Negative means the company is buying back shares.

Technical

TPE/4119 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

32.4

Neutral momentum band

Price vs 200-day MA

-13.9%

50/200-day relationship not available

Beta (5Y)

0.10

Less volatile than the market

Sharpe ratio

-1.69

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPE/4119

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpe/4119 stock rating?

tpe/4119 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpe/4119 analysis?

The full report lives at /stocks/tpe/4119/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpe/4119?

The latest report frames tpe/4119 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpe/4119 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.